Global Biopharmaceutical Contract Manufacturing (BCMO) Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Biopharmaceutical Contract Manufacturing (BCMO) Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Biopharmaceutical Contract Manufacturing (BCMO) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biopharmaceutical Contract Manufacturing (BCMO) market is projected to reach US$ 120590 million in 2034, increasing from US$ 87830 million in 2022, with the CAGR of 4.7% during the period of 2024 to 2034. Demand from Autoimmune Diseases and Oncology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biopharmaceutical Contract Manufacturing (BCMO) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biopharmaceutical Contract Manufacturing (BCMO) key companies include 3P Biopharmaceuticals, Abbvie, Aenova, Amri, Avara Pharmaceutical Services, Catalent, Cytovance Biologics, Dm Bio and Dr. Reddy’s Laboratories, etc. 3P Biopharmaceuticals, Abbvie, Aenova are top 3 players and held % share in total in 2022.
Biopharmaceutical Contract Manufacturing (BCMO) can be divided into Clinical Manufacturing and Commercial Manufacturing, etc. Clinical Manufacturing is the mainstream product in the market, accounting for % share globally in 2022.
Biopharmaceutical Contract Manufacturing (BCMO) is widely used in various fields, such as Autoimmune Diseases, Oncology, Metabolic Diseases and Infectious Diseases, etc. Autoimmune Diseases provides greatest supports to the Biopharmaceutical Contract Manufacturing (BCMO) industry development. In 2022, global % share of Biopharmaceutical Contract Manufacturing (BCMO) went into Autoimmune Diseases filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharmaceutical Contract Manufacturing (BCMO) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
3P Biopharmaceuticals
Abbvie
Aenova
Amri
Avara Pharmaceutical Services
Catalent
Cytovance Biologics
Dm Bio
Dr. Reddy’s Laboratories
Fareva
Fujifilm Diosynth Biotechnologies
Rovi Contract Manufacturing
Samsung Biologics
Syngene International
TCG Lifesciences
Teuto
Wuxi Apptec
Segment by Type
Clinical Manufacturing
Commercial Manufacturing
Autoimmune Diseases
Oncology
Metabolic Diseases
Infectious Diseases
Neurology
Respiratory Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biopharmaceutical Contract Manufacturing (BCMO) market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biopharmaceutical Contract Manufacturing (BCMO) introduction, etc. Biopharmaceutical Contract Manufacturing (BCMO) Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Biopharmaceutical Contract Manufacturing (BCMO) market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Biopharmaceutical Contract Manufacturing (BCMO) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biopharmaceutical Contract Manufacturing (BCMO) key companies include 3P Biopharmaceuticals, Abbvie, Aenova, Amri, Avara Pharmaceutical Services, Catalent, Cytovance Biologics, Dm Bio and Dr. Reddy’s Laboratories, etc. 3P Biopharmaceuticals, Abbvie, Aenova are top 3 players and held % share in total in 2022.
Biopharmaceutical Contract Manufacturing (BCMO) can be divided into Clinical Manufacturing and Commercial Manufacturing, etc. Clinical Manufacturing is the mainstream product in the market, accounting for % share globally in 2022.
Biopharmaceutical Contract Manufacturing (BCMO) is widely used in various fields, such as Autoimmune Diseases, Oncology, Metabolic Diseases and Infectious Diseases, etc. Autoimmune Diseases provides greatest supports to the Biopharmaceutical Contract Manufacturing (BCMO) industry development. In 2022, global % share of Biopharmaceutical Contract Manufacturing (BCMO) went into Autoimmune Diseases filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharmaceutical Contract Manufacturing (BCMO) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
3P Biopharmaceuticals
Abbvie
Aenova
Amri
Avara Pharmaceutical Services
Catalent
Cytovance Biologics
Dm Bio
Dr. Reddy’s Laboratories
Fareva
Fujifilm Diosynth Biotechnologies
Rovi Contract Manufacturing
Samsung Biologics
Syngene International
TCG Lifesciences
Teuto
Wuxi Apptec
Segment by Type
Clinical Manufacturing
Commercial Manufacturing
Segment by Application
Autoimmune Diseases
Oncology
Metabolic Diseases
Infectious Diseases
Neurology
Respiratory Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biopharmaceutical Contract Manufacturing (BCMO) market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biopharmaceutical Contract Manufacturing (BCMO) introduction, etc. Biopharmaceutical Contract Manufacturing (BCMO) Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Biopharmaceutical Contract Manufacturing (BCMO) market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices